Skip to content
Menu

Viridian Therapeutics, Inc. VRDN

Full chart Compare
Set alert

Price alert · VRDN

All alert types
31.44 USD +1.32 (+4.38%)

Regular-session close

31.80 +0.36 +1.15%

After hours · Nov 19, 5:28 PM ET

29.92 Day range 31.51
13.18 52-week range 34.29
YTD
+1.03%
1 year
+9.62%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$20.79MGross Profit$70.85MNet Loss$342.60MExpenses$434.24MSelling, General & Admin$95.31MResearch & Development$338.93MRevenue$70.85MLicense$70.00MCollaboration$849.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

VRDN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
70.85M302.00K314.00K1.77M2.96M
70.85M302.00K314.00K1.77M2.96M
70.85M302.00K314.00K1.77M2.96M
434.24M299.34M254.76M136.08M82.69M
338.93M238.25M159.76M100.89M56.89M
95.31M61.08M95.00M35.18M25.80M
-363.39M-299.04M-254.45M-134.30M-79.73M
4.95M2.20M1.33M486.00K3.00K
-342.60M-269.95M-237.73M-129.87M-79.41M
-342.60M-269.95M-237.73M-129.87M-79.41M
-342.60M-269.95M-237.73M-129.87M-79.41M
-342.60M-269.95M-237.73M-129.87M-79.41M
-3.32-3.07-3.91-2.71-6.66
-3.32-3.07-3.91-2.71-6.66
-3.32-3.07-3.91-2.71-6.66
-337.65M-267.75M-236.40M-129.39M-79.41M
-337.65M-267.75M-236.40M-129.39M-79.41M
84.80M67.89M44.76M32.09M11.92M
84.80M67.89M44.76M32.09M11.92M